BiotechTube
Home/Eledon Pharmaceuticals/David-Alexandre (D.A.) Gros, M.D.
D(

David-Alexandre (D.A.) Gros, M.D.

Chief Executive Officer

Eledon Pharmaceuticals

Therapeutic Areas

Organ TransplantationAutoimmune DiseasesNeurodegenerative Diseases

Eledon Pharmaceuticals Pipeline

DrugIndicationPhase
TegoprubartKidney Transplant Rejection PreventionPhase 2

Leadership Team at Eledon Pharmaceuticals

SP
Steven Perrin, Ph.D.
President and Chief Scientific Officer
View full Eledon Pharmaceuticals profile